VP of Enterprise Programs

CS Genetics is seeking a VP of Enterprise Programs to establish and scale our enterprise program motion across pharma and pharma-scale research organizations. This is a founding commercial role responsible for converting early scientific engagement into durable, repeatable enterprise programs embedded in post-HTS and secondary screening workflows.

This role sits at the intersection of enterprise deal execution, workflow design, and product–market fit. You will operate as an individual contributor initially, owning strategic accounts end-to-end while helping define how CS Genetics is adopted, expanded, and operationalized inside complex screening organizations.

Pharma is the primary ICP, but this role also owns enterprise-scale programs in major academic and translational research centers running industrial-scale drug screening.

The Head of Enterprise Programs reports to the Chief Marketing Officer and works closely with the CEO, product, and scientific leadership.

• Own and execute enterprise programs with top-tier pharma and pharma-scale research organizations.
• Lead deals from initial engagement through pilot, program expansion, and platform-level adoption.
• Serve as the primary commercial owner of long-cycle, high-complexity enterprise relationships.

• Design programs that embed CS Genetics’ single-cell platform and Navigator decision layer into post-HTS, secondary screening, and MoA workflows.
• Translate scientific value into clear program structure: scope, success criteria, decision points, and expansion paths.
• Shape how customers operationalize Simple Cell and Navigator as part of their existing screening cascades.

• Act as the front-line signal for product–market fit, feeding concrete customer insight back into product, pricing, and roadmap decisions.
• Partner with marketing to refine positioning, use-case definition, and program narratives based on real adoption patterns.
• Help define what “enterprise readiness” means across scientific, operational, and commercial dimensions.

• Work closely with the CEO, CMO, and technical leadership to align commercial strategy with platform capabilities.
• Help define future commercial roles, handoffs, and structure as the enterprise motion matures.
• Operate without a sales team initially, setting the foundation for future scale.

• 10+ years of experience selling, building, or operating enterprise programs in pharma or pharma-adjacent environments.
• Deep familiarity with high-throughput screening (HTS), secondary screening, MoA studies, or related discovery workflows.
• Proven ability to navigate complex buying groups (scientific, translational, informatics, and platform stakeholders).
• Track record of closing and expanding high-value, long-cycle enterprise engagements.
• Comfort operating independently in ambiguous, early-stage environments without a predefined playbook.

• Strong working knowledge of drug discovery workflows and decision-making processes.
• Broad familiarity with transcriptomics, omics, or advanced screening readouts; single-cell expertise is helpful but not required.
• Ability to engage credibly with senior scientific and translational leaders.

• Experience selling platforms, workflows, or decision-support systems (not just tools or consumables).